Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks

Cephalalgia

Volumn 29, Issue 11, 2009, Pages 1133-1148

  Brandes, Jl ^a   Poole, Ac ^b   Kallela, M ^c   Schreiber, Cp ^d   MacGregor, Ea ^e   Silberstein, Sd ^f   Tobin, J ^g   Shaw, R ^g  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sjolyst Medical Centre   (Norway)

^c Helsinki Headache Centre   (Finland)

^d HEADACHE CARE CENTER   (United States)

^e City of London Migraine Clinic   (United Kingdom)

^f THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^g Vernalis Development Ltd   (United Kingdom)

Author keywords

Frovatriptan; Headache; Menstrual migraine; Migraine; Short term prevention

Indexed keywords

FROVATRIPTAN; PLACEBO; RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INGUINAL HERNIA; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUAL MIGRAINE; NAUSEA; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; CARBAZOLES; DOUBLE-BLIND METHOD; FEMALE; HISTORY, 16TH CENTURY; HUMANS; MENSTRUATION; MIDDLE AGED; MIGRAINE DISORDERS; SEROTONIN AGONISTS; TRYPTAMINES; YOUNG ADULT;

EID: 70349667447     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01840.x     Document Type: Article

References (24)

1. Couturier EGM, Bomhof MAM, Neven AK, van Duijn NP. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003 23 : 302 308.
2. MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004 63 : 351 353.
3. Somerville BW. The influence of hormonal changes upon migraine in women. Proc Aust Assoc Neurol 1971 8 : 47 53.
4. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972 22 : 355 365.
5. MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 2006 67 : 2159 2163.
6. Welch KM, Brandes JL, Berman NE. Mismatch in how oestrogen modulates molecular and neuronal function may explain menstrual migraine. Neurol Sci 2006 27 (Suppl. 2 S190 2.
7. Granella F, Sances G, Allais G, Nappi RE, Tirelli A, Benedetto C et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 2004 24 : 707 716.
8. Landy S, Savani N, Shackelford S, Loftus J, Jones M. Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine. Int J Clin Pract 2004 58 : 913 919.
9. Massiou H, Jamin C, Hinzelin G, Bidaut-Mazel C. Efficacy of oral naratriptan in the treatment of menstrually related migraine. Eur J Neurol 2005 12 : 774 781.
10. Allais G, Acuto G, Cabarrocas X, Esbri R, Benedetto C, Bussone G. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurol Sci 2006 27 : S193 7.
11. Nett R, Landy S, Shackelford S, Richardson MS, Ames M, Lener M. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine. Obstet Gynecol 2003 102 : 835 842.
12. Silberstein SD, Massiou H, Le Jeunne C, Johnson-Pratt L, McCarroll KA, Lines CR. Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol 2000 96 : 237 242.
13. Hamel E. Serotonin and migraine: biology and clinical implications. Cephalalgia 2007 27 : 1293 1300.
14. Brandes JL. The influence of estrogen on migraine: a systematic review. JAMA 2006 295 : 1824 1830.
15. Newman L, Mannix LK, Landy S, Silberstein S, Lipton RB, Putnam DG et al. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache 2001 41 : 248 256.
16. Silberstein SD, Elkind AH, Schreiber C, Keywood C. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 2004 63 : 261 269.
17. Tuchman M, Hee A, Emeribe U. Oral zolmitriptan 2.5 mg demonstrates high efficacy and good tolerability in the prophylaxis treatment of menstrual migraine headaches. Headache 2005 45 : 771 772.
18. Mannix LK, Savani N, Landy S, Valade D, Shackelford S, Ames MH et al. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies. Headache 2007 47 : 1037 1049.
19. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders: 2nd edn. Cephalalgia 2004 24 (Suppl. 1 9 160.
20. Wade A, Warrington S, Whale H, Pawsey S, Gammaitoni A. Pharmacokinetics and tolerability in healthy subjects of 6-day frovatriptan dosing regimen used for the short-term prevention of menstrual migraine. Headache 2006 46 : 844.
21. Tfelt-Hansen P, Block G, Dahlof C, Diener HC, Ferrari MD, Goadsby PJ et al. Guidelines for controlled trials of drugs in migraine: 2nd edn. Cephalalgia 2000 20 : 765 786.
22. Whitehead J. Sample size calculations for ordered categorical data. Stat Med 1993 12 : 2257 2271.
23. Tuchman M, Hee A, Emeribe U, Silberstein S. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine. CNS Drugs 2006 20 : 1019 1026.
24. Coeytaux RR, Frasier PY, Reid A. Patient-centered outcomes for frequent headaches. Headache 2007 47 : 480 485.